The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
<h4>Background</h4>The aim of the present meta-analysis was to evaluate the effect of disease-modifying drugs (DMD) on brain atrophy in patients with relapsing-remitting multiple sclerosis (RRMS) using available randomized-controlled trial (RCT) data.<h4>Methods</h4>We conduc...
Saved in:
| Main Authors: | Georgios Tsivgoulis, Aristeidis H Katsanos, Nikolaos Grigoriadis, Georgios M Hadjigeorgiou, Ioannis Heliopoulos, Constantinos Kilidireas, Konstantinos Voumvourakis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0116511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
by: Georgios Tsivgoulis, et al.
Published: (2015-01-01) -
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
by: Juan Ignacio Rojas, et al.
Published: (2012-08-01) -
AI-driven MRI analysis reveals brain atrophy patterns in benign relapsing-remitting multiple sclerosis
by: M. Niiranen, et al.
Published: (2025-05-01) -
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01) -
Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01)